Specific detection of Epstein-Barr virus in inflammatory pseudotumor of the spleen in a patient with a high serum level of soluble IL-2 receptor

Journal of Gastroenterology

Volumn 35, Issue 7, 2000, Pages 563-566

  Yamaguchi, Masahiko ^a   Yamamoto, Takako ^a   Tate, Genshu ^a   Matsumoto, Tadashi ^a   Matsumiya, Akihiko ^a   Kuzume, Masaoh ^a   Sanada, Yutaka ^a   Kumada, Kaoru ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Epstein barr virus; Inflammatory pseudotumor; Soluble interleukin 2 receptor; Spleen

Indexed keywords

INTERLEUKIN 2 RECEPTOR; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; INFLAMMATION; PRIORITY JOURNAL; PSEUDOTUMOR; SPLEEN TUMOR; SPLENECTOMY; TUMOR BIOPSY; VIRUS DETECTION; VIRUS INFECTION;

EID: 0033910792     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350070082     Document Type: Article

References (13)

1. Cotelingam JD, Jaffe ES. Inflammatory pseudotumor of the spleen. Am J Surg Pathol 1984;8:375-80.
2. Thomas RM, Jaffe ES, Zarale-Osorno A, Medeiros LJ. Inflammatory pseudotumor of the spleen. A clinicopalhologic and immunophenotypic study of eight cases. Arch Pathol Lab Med 1993;117:921-6.
3. Wagner DK, Kiwanuka J, Edwards BK, Rubin LA, Nelson DL, Magrath IT. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol 1987;5:1262-74.
4. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 1994;145: 239-52.
5. McHenry CR, Perzy-Gall HB, Mardini G, Chung-Park M. Inflammatory pseudotumor of the spleen: a rare entity that mimics hematopoietic malignancy. Am Surg 1995;61:1067-71.
6. Irie H, Honda H, Kancko K, Kuroiwa T, Fukuya T, Yoshimitsu K, et al. Inflammatory pseudotumors of the spleen: CT and MRI findings. J Comput Assist Tomogr 1996;20:244-8.
7. Harrington DS, Patil K, Lai PK, Yasuda NN, Armitage JO, Ip SH, et al. Soluble interleukin 2 receptors in patients with malignant lymphoma. Arch Pathol Lab Med 1988;112:597-601.
8. Kube D, Vockerodt M, Weber O, Hell K, Haier B, Grasser FA, et al. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. J Virol 1999;73:1630-6.
9. Arber DA, Weiss LM, Chang KL. Detection of Epstein-Barr virus in inflammatory pseudotumor. Semin Diagn Pathol 1998;15: 155-60.
10. Arber DA, Kamel OW, van de Rijn M, Davis RE. Medeiros LJ, Jaffe ES, et al. Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol 1995;26:1093-8.
11. Timmons CF, Dawson DB, Richards CS, Andrews WS, Katz JA. Epstein-Barr virus-associated leiomyosarcomas in liver transplantation recipients. Cancer 1995;76:1481-9.
12. Hermann TE, Shackelford GD, Ternberg JL, Dehner LP. Inflammatory myofibroblastic tumor of the spleen: report of a case in an adolescent. Pediatr Radiol 1994;24:280-2.
13. Donner LR, Trompler RA, White RR IV. Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol 1996;27:1095-8.